WO2005079578A2 - Embedded biocide - Google Patents
Embedded biocide Download PDFInfo
- Publication number
- WO2005079578A2 WO2005079578A2 PCT/GB2005/000640 GB2005000640W WO2005079578A2 WO 2005079578 A2 WO2005079578 A2 WO 2005079578A2 GB 2005000640 W GB2005000640 W GB 2005000640W WO 2005079578 A2 WO2005079578 A2 WO 2005079578A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- phosphonium
- compound
- phosphonium compound
- matrix substrate
- tetrakis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
- A01N57/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-carbon bonds
- A01N57/20—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-carbon bonds containing acyclic or cycloaliphatic radicals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
- A01N57/34—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-halogen bonds; Phosphonium salts
Definitions
- This invention relates to a phosphonium compound embedded in a matrix substrate, the use of such an embedded phosphonium compound and a method of using an embedded phosphonium compound.
- Phosphonium compounds such as THP (tris (hydroxymethyl) phosphine) and its associated salts, THP sulphate and THP chloride, are effective biocides and scale dissolvers that are widely used in water treatment and oil field applications for the control of micro-organisms and scale.
- micro-organisms include sulphate reducing bacteria, general heterotrophic bacteria and algae. These micro-organisms are responsible for scale formation in aqueous systems found in industry.
- the scale comprises, iron carbonate or iron, lead and zinc sulphide deposits.
- Phosphonium compounds are conventionally supplied as liquid based products, but solid forms of phosphonium compounds are commercially available. Solid forms typically comprise phosphonium compounds coated onto a solid, inert, substrate such as adipic acid.
- Liquid based phosphonium compounds react or interfere with the performance of commonly used oxygen scavengers.
- oxygen scavengers For example, sulphite based scavengers and erythorbic acid, with the result being that complete deaeration of systems containing liquid based phosphonium compounds is difficult to achieve.
- the present invention provides a phosphonium compound embedded in a matrix substrate wherein the phosphonium compound is selected from the group consisting of tris (hydroxyorgano) phosphine (THP) , a THP + salt (tetrakis (hydroxyorgano) phosphonium salt) or a condensate of THP and a nitrogen containing compound.
- THP tris (hydroxyorgano) phosphine
- THP + salt tetrakis (hydroxyorgano) phosphonium salt
- condensate of THP and a nitrogen containing compound a condensate of THP and a nitrogen containing compound.
- the embedded phosphonium compound can be used for applications that neither conventional liquid or solid forms of the phosphonium compound are suitable for;
- the resulting product can be dosed into system requiring deaeration, for example, oil field water injection systems and transmission pipelines during hydrostatic testing; without impacting upon the performance of the oxygen scavenger;
- a delivery system for phosphonium compounds is provided that enables the phosphonium compound to be dosed into systems containing oxygen scavengers without incompatibility problems. This is not currently possible;
- a delivery system for a phosphonium compound is provided that does not adversely affect the performance of the phosphonium compound or the overall treatment program used in aqueous systems;
- a delayed release system is provided that allows sustained controlled dissolution of the phosphonium compound into aqueous systems
- a delivery system is provided whereby the rates of dissolution of the embedded phosphonium compound can be controlled by the matrix composition;
- a delivery system is provided that minimises direct contact with the biocide;
- a delivery system is provided which is deployable in areas of low expertise and an absence of mechanical equipment, for example, pumps;
- a delivery system is provided that allows phosphonium compounds to be formulated with other treatment chemicals or enhancers that would normally be incompatible if initially combined with an aqueous solution.
- the THP + salt is tetrakis (hydroxymethyl) phosphonium sulphate.
- the THP + salt is tetrakis (hydroxymethyl) phosphonium chloride, tetrakis (hydroxymethyl) phosphonium phosphate, tetrakis (hydroxymethyl) phosphonium formate, tetrakis (hydroxymethyl) phosphonium acetate or tetrakis (hydroxymethyl) phosphonium oxalate.
- the nitrogen containing compound is preferably urea. Alternatively, it may be melamine, guanidine or dicyandiamide.
- the matrix substrate has a melting point of between 5 to 80° C.
- the melting point is between 20 to 70° C. More preferably, the melting point is 60° C.
- the matrix substrate is soluble in water at a temperature of between 5 to 100° C, especially 20°C.
- the matrix substrate is preferably selected from a polyhydric compound.
- the polyhydric compound is a polyethylene glycol with a molecular weight of above 600. More preferably, the polyhydric compound is polyethylene glycol 8000.
- the matrix substrate is selected from the group consisting of ethoxylated surfactants, fatty alcohols, ethoxylated fatty alcohols, ethoxylated alkyl phenols, ethoxylated fatty acids, fatty acid alkanolamides, ethylene oxide/propylene oxide block copolymers, ethoxylated/propoxylated fatty alcohols, polyethylene glycol esters, glycol esters, alkyl benzene sulphonic acids and salts thereof.
- the matrix substrate may be a mixture of two or more of the compounds selected above.
- the present invention also provides in a second aspect the use of a phosphonium compound as defined in the first aspect.
- the phosphonium compound is used to reduce the numbers of micro-organisms in industrial systems.
- the phosphonium compound is used to reduce iron carbonate or iron, lead and zinc scale deposits .
- the industrial system is selected from the group consisting of storage vessels for water and fuel; fuel and gas pipelines; gas lift wells; water injection systems; oil or gas production wells; cooling tower aqueous systems; aqueous systems in paper production and the like and any other aqueous system where micro-organism contamination is a problem.
- the micro-organism is selected from the group consisting of sulphate reducing bacteria, general heterotrophic bacteria and algae.
- the present invention provides a method for reducing the numbers of micro-organisms in an industrial system which method comprises the step of contacting the industrial system with an effective amount of a phosphonium compound as defined in the first aspect of the invention to reduce the number of micro-organisms.
- the present invention provides a method for reducing the amount of scale in an industrial system which method comprises the step of contacting the industrial system with an effective amount of a phosphonium compound as defined in the first aspect of the invention to reduce the amount of scale.
- the phosphonium compound according to the first aspect may be formulated with one or more of the following: scale inhibitors, corrosion inhibitors, additional biocides, demulsifiers, gas hydrate inhibitors, asphaltene inhibitors/dispersants, other surfactants, anti-foams/defoamers, fragrances, wax inhibitors, scale dissolvers, gelling agents, oxygen scavengers.
- the embedded biocide in accordance with the invention may be in the form of sticks/candles, beads, pellets, bricks, shavings, flakes or prills and the like.
- Example 1 A polyethylene glycol with a weight average molecular weight of 8000 (PEG8000) is used to produce matrix substrate containing THPS, that has a melting point of approximately 50 °C (suitable for storage in most areas of the world) and readily dissolving within 5 minutes in water at 20° C.
- PEG8000 polyethylene glycol with a weight average molecular weight of 8000
- THPS embedded within a PEG8000 matrix
- THPS can be deployed in the presence of an oxygen scavenger without hindering the deaeration process.
- Experiment three shows complete deaeration within 15 seconds when an embedded biocide in accordance with the present invention is used, compared with no deaeration when a liquid biocide is used (Experiment 2).
- Example 3 The THPS/PEG8000 candle described above was tested in a standard quantitative suspension test to measure the antimicrobial activity of the embedded biocide. Such tests involve the addition of the biocide to the system water for a specified contact period, deactivation of the biocide after the specified contact period and subsequent enumeration of the remaining viable bacteria using Most Probable Number (MPN) techniques widely known within the industry.
- MPN Most Probable Number
- the control shows the viability of the bacteria when not exposed to THPS.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Paints Or Removers (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
A phosphonium compound embedded in a matrix substrate wherein the phosphonium compound is selected from a group consisting of tris (hydroxyorgano) phosphine (THP), a THP+ salt (tetrakis (hydroxyorgano) phosphonium salt) or a condensate of THP and a nitrogen containing compound. The compound may be used to reduce the numbers of micro organisms in industrial systems and may also be used to reduce iron carbonate or iron, lead and zinc scale deposits.
Description
EMBEDDED BIOCIDE
This invention relates to a phosphonium compound embedded in a matrix substrate, the use of such an embedded phosphonium compound and a method of using an embedded phosphonium compound.
Phosphonium compounds, such as THP (tris (hydroxymethyl) phosphine) and its associated salts, THP sulphate and THP chloride, are effective biocides and scale dissolvers that are widely used in water treatment and oil field applications for the control of micro-organisms and scale. Such micro-organisms include sulphate reducing bacteria, general heterotrophic bacteria and algae. These micro-organisms are responsible for scale formation in aqueous systems found in industry. Typically the scale comprises, iron carbonate or iron, lead and zinc sulphide deposits.
Phosphonium compounds are conventionally supplied as liquid based products, but solid forms of phosphonium compounds are commercially available. Solid forms typically comprise phosphonium compounds coated onto a solid, inert, substrate such as adipic acid.
Liquid based phosphonium compounds react or interfere with the performance of commonly used oxygen scavengers. For example, sulphite based scavengers and erythorbic acid, with the result being that complete deaeration of systems containing liquid based phosphonium compounds is difficult to achieve.
Accordingly, the present invention provides a phosphonium compound embedded in a matrix substrate wherein the phosphonium compound is selected from the group consisting of tris (hydroxyorgano) phosphine (THP) , a THP+ salt (tetrakis (hydroxyorgano) phosphonium salt) or a condensate of THP and a nitrogen containing compound.
The present invention offers the following advantages :-
The embedded phosphonium compound can be used for applications that neither conventional liquid or solid forms of the phosphonium compound are suitable for;
With the phosphonium compound embedded in a matrix substrate, the resulting product can be dosed into system requiring deaeration, for example, oil field water injection systems and transmission pipelines during hydrostatic testing; without impacting upon the performance of the oxygen scavenger;
A delivery system for phosphonium compounds is provided that enables the phosphonium compound to be dosed into systems containing oxygen scavengers without incompatibility problems. This is not currently possible;
A delivery system for a phosphonium compound is provided that does not adversely affect the performance of the phosphonium compound or the overall treatment program used in aqueous systems;
A delayed release system is provided that allows sustained controlled dissolution of the phosphonium compound into aqueous systems;
A delivery system is provided whereby the rates of dissolution of the embedded phosphonium compound can be controlled by the matrix composition;
A delivery system is provided that minimises direct contact with the biocide;
A delivery system is provided which is deployable in areas of low expertise and an absence of mechanical equipment, for example, pumps;
A delivery system is provided that allows phosphonium compounds to be formulated with other treatment chemicals or enhancers that would normally be incompatible if initially combined with an aqueous solution.
Preferably the THP+ salt is tetrakis (hydroxymethyl) phosphonium sulphate. Alternatively, the THP+ salt is tetrakis (hydroxymethyl) phosphonium chloride, tetrakis (hydroxymethyl) phosphonium phosphate, tetrakis (hydroxymethyl) phosphonium formate, tetrakis (hydroxymethyl) phosphonium acetate or tetrakis (hydroxymethyl) phosphonium oxalate.
The nitrogen containing compound is preferably urea. Alternatively, it may be melamine, guanidine or dicyandiamide.
The matrix substrate has a melting point of between 5 to 80° C. Preferably the melting point is between 20 to 70° C. More preferably, the melting point is 60° C.
Preferably the matrix substrate is soluble in water at a temperature of between 5 to 100° C, especially 20°C.
The matrix substrate is preferably selected from a polyhydric compound. Preferably the polyhydric compound is a polyethylene glycol with a molecular weight of above 600. More preferably, the polyhydric
compound is polyethylene glycol 8000. Alternatively, the matrix substrate is selected from the group consisting of ethoxylated surfactants, fatty alcohols, ethoxylated fatty alcohols, ethoxylated alkyl phenols, ethoxylated fatty acids, fatty acid alkanolamides, ethylene oxide/propylene oxide block copolymers, ethoxylated/propoxylated fatty alcohols, polyethylene glycol esters, glycol esters, alkyl benzene sulphonic acids and salts thereof.
The matrix substrate may be a mixture of two or more of the compounds selected above.
The present invention also provides in a second aspect the use of a phosphonium compound as defined in the first aspect.
Preferably, the phosphonium compound is used to reduce the numbers of micro-organisms in industrial systems. Alternatively, the phosphonium compound is used to reduce iron carbonate or iron, lead and zinc scale deposits .
The industrial system is selected from the group consisting of storage vessels for water and fuel; fuel and gas pipelines; gas lift wells; water injection systems; oil or gas production wells; cooling tower aqueous systems; aqueous systems in paper production and the like and any other aqueous system where micro-organism contamination is a problem.
Preferably the micro-organism is selected from the group consisting of sulphate reducing bacteria, general heterotrophic bacteria and algae.
According to a third aspect, the present invention provides a method for reducing the numbers of micro-organisms in an industrial system which method comprises the step of contacting the industrial system with an
effective amount of a phosphonium compound as defined in the first aspect of the invention to reduce the number of micro-organisms.
According to a fourth aspect, the present invention provides a method for reducing the amount of scale in an industrial system which method comprises the step of contacting the industrial system with an effective amount of a phosphonium compound as defined in the first aspect of the invention to reduce the amount of scale.
The phosphonium compound according to the first aspect may be formulated with one or more of the following: scale inhibitors, corrosion inhibitors, additional biocides, demulsifiers, gas hydrate inhibitors, asphaltene inhibitors/dispersants, other surfactants, anti-foams/defoamers, fragrances, wax inhibitors, scale dissolvers, gelling agents, oxygen scavengers.
The embedded biocide in accordance with the invention may be in the form of sticks/candles, beads, pellets, bricks, shavings, flakes or prills and the like.
An embodiment of the invention will now be described with reference to the following examples:
Example 1 A polyethylene glycol with a weight average molecular weight of 8000 (PEG8000) is used to produce matrix substrate containing THPS, that has a melting point of approximately 50 °C (suitable for storage in most areas of the world) and readily dissolving within 5 minutes in water at 20° C.
Example 2
As shown in Table 1 below, THPS, embedded within a PEG8000 matrix, can be deployed in the presence of an oxygen scavenger without hindering the deaeration process. Experiment three shows complete deaeration within 15 seconds when an embedded biocide in accordance with the present invention is used, compared with no deaeration when a liquid biocide is used (Experiment 2).
Example 3 The THPS/PEG8000 candle described above was tested in a standard quantitative suspension test to measure the antimicrobial activity of the embedded biocide. Such tests involve the addition of the biocide to the system water for a specified contact period, deactivation of the biocide after the specified contact period and subsequent enumeration of the remaining viable bacteria using Most Probable Number (MPN) techniques widely known within the industry.
From the graph below (Graph 1) it can be seen that THPS embedded in a PEG8000 matrix substrate (Tolcide® candle H2) has no adverse effects upon the antimicrobial performance of THPS when compared with liquid THPS (Tolcide® PS75).
The control shows the viability of the bacteria when not exposed to THPS.
Table 1
PERFORMANCE OF TOLCIDE PS75 CANDLES TYPE H2 vs TOLCIDE PS 75 (allat40mg/ITHPS)
Graph 1
Claims
1. A phosphonium compound embedded in a matrix substrate wherein the phosphonium compound is selected from a group consisting of tris (hydroxyorgano) phosphine (THP), a THP+ salt (tetrakis (hydroxyorgano) phosphonium salt) or a condensate of THP and a nitrogen containing compound.
2. A phosphonium compound as claimed in claim 1, in which the THP+ salt is tetrakis (hydroxymethyl) phosphonium sulphate.
3. A phosphonium compound as claimed in claim 1, in which the THP salt is selected from the group consisting of tetrakis (hydroxymethyl) phosphonium chloride, tetrakis (hydroxymethyl) phosphonium phosphate, tetrakis (hydroxymethyl) phosphonium formate, tetrakis (hydroxymethyl) phosphonium acetate and tetrakis (hydroxymethyl) phosphonium oxalate.
4. A phosphonium compound as claimed in any preceding claim, in which the nitrogen containing compound is urea.
5. A phosphonium compound as claimed in any one of claims 1 to 3, in which the nitrogen containing compound is melamine, guanidine or dicyandiamide.
6. A phosphonium compound as claimed in anyone of the preceding claims, in which the matrix substrate has a melting point of between 5 to 80° C.
7. A phosphonium compound as claimed in claim 6, in which the matrix substrate has a melting point of between 20 to 70° C.
8. A phosphonium compound as claimed in claim 7, in which the matrix substrate has a melting point of 60° C.
9. A phosphonium compound as claimed in anyone of the preceding claims, in which the matrix substrate is soluble in water at a temperature of between 5 to 100° C.
10. A phosphonium compound as claimed in claim 9, in which the matrix substrate is soluble in water at a temperature of 20° C.
11. A phosphonium compound as claimed in anyone of the preceding claims in which the matrix substrate is selected from a polyhydric compound.
12. A phosphonium compound as claimed in claim 11, in which the polyhydric compound is a polyethylene glycol with a molecular weight of above 600.
13. A phosphonium compound as claimed in claim 11, in which the polyhydric compound is polyethylene glycol 8000.
14. A phosphonium compound as claimed in anyone of claims 1 to 10 in which the matrix substrate is selected from a group consisting of ethoxylated surfactants, fatty alcohols, ethoxylated fatty alcohols, ethoxylated alkyl phenols, ethoxylated fatty acids, fatty acid alkanolamides, ethylene oxide/propylene oxide block copolymers, ethoxylated/propoxylated fatty alcohols, polyethylene glycol esters, glycol esters, alkyl benzene sulphonic acids and salts thereof.
15. A phosphonium compound as claimed in any one of the preceding claims, wherein the matrix substrate is a mixture of two or more of the polyhydric compound defined in any one of claims 12 to 14.
16. The use of a phosphonium compound as defined in claims 1 to 15.
17. The use of a phosphonium compound as claimed in any one of claims 1 to 15 to reduce the numbers of micro-organisms in industrial systems.
18. The use of phosphonium compound as claimed in claim 17 in which the industrial system is selected from the group consisting of storage vessels for water and fuel; fuel and gas pipelines; gas lift wells; water injection systems; oil or gas production wells; cooling tower aqueous systems; aqueous systems in paper reduction and the like and any other aqueous systems where micro-organism contamination is a problem.
19. The use of phosphonium compound as claimed in claim 17 or claim 18, in which the micro-organism is selected from the group consisting of sulphate reducing bacteria, general heterotrophic bacteria and algae.
20. The use of phosphonium compound as claimed in any one of claims 1 to 15 to reduce iron carbonate or iron, lead and zinc scale deposits.
21. A method for reducing the numbers of micro-organisms in an industrial system which method comprises a step of contacting the industrial system with an effective amount of phosphonium compound as defined in anyone of claims 1 to 15 to reduce the number of microorganisms .
22. A method for reducing the amount of scale in an industrial system which method comprises the step of contacting the industrial system with an effective amount of a phosphonium compound defined in anyone of claims 1 to 15 to reduce the amount of scale.
23. A phosphonium compound as claimed in any one of claims 1 to 15, in which said compound is formulated with one or more of the following: scale inhibitors, corrosion inhibitors, additional biocides, demulsif iers , gas hydrate inhibitors, asphaltene inhibitors/dispersants, other surfactants, anti-foams/defoamers, fragrances, wax inhibitors, scale dissolvers, gelling agents, oxygen scavengers.
24. A phosphonium compound as claimed in any one of claims 1 to 15, in which said compound is in the form of sticks/candles, beads, pellets, bricks, shavings, flakes or prills.
25. A phosphonium compound substantially as described herein with reference to the examples.
26. The use of a phosphonium compound substantially as described herein.
27. A method for reducing the numbers of micro-organisms in an industrial system substantially as described herein.
28. A method for reducing the amount of scale in an industrial system substantially described herein.
Priority Applications (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2005800054392A CN1921762B (en) | 2004-02-20 | 2005-02-21 | Embedded biocide |
| US10/589,210 US20080032949A1 (en) | 2004-02-20 | 2005-02-21 | Embedded Biocide |
| DK05708421T DK1715744T3 (en) | 2004-02-20 | 2005-02-21 | Embedded biocide |
| AU2005213883A AU2005213883B2 (en) | 2004-02-20 | 2005-02-21 | Embedded biocide |
| DE602005009144T DE602005009144D1 (en) | 2004-02-20 | 2005-02-21 | EMBEDDED BIOZIDE |
| CA2557585A CA2557585C (en) | 2004-02-20 | 2005-02-21 | Biocide composition including a phosphonium compound embedded in a matrix substrate |
| EP05708421A EP1715744B1 (en) | 2004-02-20 | 2005-02-21 | Embedded biocide |
| BRPI0506547-0A BRPI0506547A (en) | 2004-02-20 | 2005-02-21 | phosphonium compounds, uses of a phosphonium compound, processes for reducing the number of microorganisms and the amount of tartar |
| MXPA06009348A MXPA06009348A (en) | 2004-02-20 | 2005-02-21 | Embedded biocide. |
| NO20063513A NO20063513L (en) | 2004-02-20 | 2006-08-01 | Included biocide |
| US12/951,936 US20110287077A1 (en) | 2004-02-20 | 2010-11-22 | Embedded biocide |
| US13/449,252 US20130022657A1 (en) | 2004-02-20 | 2012-04-17 | Embedded biocide |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0403773.5 | 2004-02-20 | ||
| GBGB0403773.5A GB0403773D0 (en) | 2004-02-20 | 2004-02-20 | Embedded biocide |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US58921007A Continuation | 2004-02-20 | 2007-05-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2005079578A2 true WO2005079578A2 (en) | 2005-09-01 |
| WO2005079578A3 WO2005079578A3 (en) | 2005-11-03 |
Family
ID=32040063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/GB2005/000640 WO2005079578A2 (en) | 2004-02-20 | 2005-02-21 | Embedded biocide |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US20080032949A1 (en) |
| EP (1) | EP1715744B1 (en) |
| CN (1) | CN1921762B (en) |
| AT (1) | ATE405162T1 (en) |
| AU (1) | AU2005213883B2 (en) |
| BR (1) | BRPI0506547A (en) |
| CA (1) | CA2557585C (en) |
| DE (1) | DE602005009144D1 (en) |
| DK (1) | DK1715744T3 (en) |
| GB (1) | GB0403773D0 (en) |
| MX (1) | MXPA06009348A (en) |
| NO (1) | NO20063513L (en) |
| RU (1) | RU2333642C2 (en) |
| WO (1) | WO2005079578A2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013525439A (en) * | 2010-04-28 | 2013-06-20 | アルコン リサーチ， リミテッド | Pharmaceutical composition comprising a phosphonium antibacterial agent |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7833551B2 (en) | 2004-04-26 | 2010-11-16 | Conocophillips Company | Inhibition of biogenic sulfide production via biocide and metabolic inhibitor combination |
| US8614170B2 (en) * | 2008-12-30 | 2013-12-24 | Schlumberger Technology Corporation | Method for treating fracturing water |
| US8211835B2 (en) | 2009-09-24 | 2012-07-03 | Schlumberger Technology Corporation | Composition and method for slickwater application |
| JP5745705B2 (en) | 2013-06-10 | 2015-07-08 | 住友精化株式会社 | Fracturing fluid viscosity control agent used in hydraulic fracturing |
| WO2017035445A1 (en) * | 2015-08-26 | 2017-03-02 | Rhodia Operations | High performance eco-friendly non-emulsifier |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0215562A1 (en) * | 1985-08-06 | 1987-03-25 | Albright & Wilson Limited | Biocidal mixtureand method for the treatment of water |
| EP0275207A2 (en) * | 1987-01-16 | 1988-07-20 | Albright & Wilson Limited | Pharmaceutical and veterinary compositions |
| WO1999017614A1 (en) * | 1997-10-04 | 1999-04-15 | Albright & Wilson Uk Limited | Phosphonium salt composition |
| EP1036498A2 (en) * | 1999-02-18 | 2000-09-20 | Baker Hughes Incorporated | Dry biocide |
| WO2001094744A1 (en) * | 2000-06-06 | 2001-12-13 | T R Oil Services Limited | Microcapsule well treatment |
| WO2002008127A1 (en) * | 2000-07-20 | 2002-01-31 | Rhodia Consumer Specialties Limited | Treatment of iron sulphide deposits |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6555228B2 (en) * | 2000-10-16 | 2003-04-29 | Dennis A. Guritza | Bio-supportive medium, and methods of making and using the same |
| US20030207270A1 (en) * | 2001-03-09 | 2003-11-06 | Kung Patrick C. | Phytomics: a genomic-based approach to herbal compositions |
-
2004
- 2004-02-20 GB GBGB0403773.5A patent/GB0403773D0/en not_active Ceased
-
2005
- 2005-02-21 EP EP05708421A patent/EP1715744B1/en not_active Not-in-force
- 2005-02-21 WO PCT/GB2005/000640 patent/WO2005079578A2/en active IP Right Grant
- 2005-02-21 US US10/589,210 patent/US20080032949A1/en not_active Abandoned
- 2005-02-21 CN CN2005800054392A patent/CN1921762B/en not_active Expired - Fee Related
- 2005-02-21 AU AU2005213883A patent/AU2005213883B2/en not_active Ceased
- 2005-02-21 DE DE602005009144T patent/DE602005009144D1/en not_active Expired - Fee Related
- 2005-02-21 BR BRPI0506547-0A patent/BRPI0506547A/en not_active Application Discontinuation
- 2005-02-21 AT AT05708421T patent/ATE405162T1/en not_active IP Right Cessation
- 2005-02-21 CA CA2557585A patent/CA2557585C/en not_active Expired - Fee Related
- 2005-02-21 MX MXPA06009348A patent/MXPA06009348A/en active IP Right Grant
- 2005-02-21 RU RU2006133537/15A patent/RU2333642C2/en not_active IP Right Cessation
- 2005-02-21 DK DK05708421T patent/DK1715744T3/en active
-
2006
- 2006-08-01 NO NO20063513A patent/NO20063513L/en not_active Application Discontinuation
-
2010
- 2010-11-22 US US12/951,936 patent/US20110287077A1/en not_active Abandoned
-
2012
- 2012-04-17 US US13/449,252 patent/US20130022657A1/en not_active Abandoned
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0215562A1 (en) * | 1985-08-06 | 1987-03-25 | Albright & Wilson Limited | Biocidal mixtureand method for the treatment of water |
| EP0275207A2 (en) * | 1987-01-16 | 1988-07-20 | Albright & Wilson Limited | Pharmaceutical and veterinary compositions |
| WO1999017614A1 (en) * | 1997-10-04 | 1999-04-15 | Albright & Wilson Uk Limited | Phosphonium salt composition |
| EP1036498A2 (en) * | 1999-02-18 | 2000-09-20 | Baker Hughes Incorporated | Dry biocide |
| WO2001094744A1 (en) * | 2000-06-06 | 2001-12-13 | T R Oil Services Limited | Microcapsule well treatment |
| WO2002008127A1 (en) * | 2000-07-20 | 2002-01-31 | Rhodia Consumer Specialties Limited | Treatment of iron sulphide deposits |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013525439A (en) * | 2010-04-28 | 2013-06-20 | アルコン リサーチ， リミテッド | Pharmaceutical composition comprising a phosphonium antibacterial agent |
Also Published As
| Publication number | Publication date |
|---|---|
| US20110287077A1 (en) | 2011-11-24 |
| GB0403773D0 (en) | 2004-03-24 |
| AU2005213883B2 (en) | 2008-06-26 |
| CA2557585A1 (en) | 2005-09-01 |
| CN1921762B (en) | 2011-02-23 |
| DE602005009144D1 (en) | 2008-10-02 |
| US20080032949A1 (en) | 2008-02-07 |
| NO20063513L (en) | 2006-11-16 |
| WO2005079578A3 (en) | 2005-11-03 |
| RU2006133537A (en) | 2008-03-27 |
| CN1921762A (en) | 2007-02-28 |
| MXPA06009348A (en) | 2007-03-07 |
| RU2333642C2 (en) | 2008-09-20 |
| CA2557585C (en) | 2012-12-04 |
| US20130022657A1 (en) | 2013-01-24 |
| EP1715744B1 (en) | 2008-08-20 |
| AU2005213883A1 (en) | 2005-09-01 |
| BRPI0506547A (en) | 2007-02-27 |
| DK1715744T3 (en) | 2008-11-24 |
| EP1715744A2 (en) | 2006-11-02 |
| ATE405162T1 (en) | 2008-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20130022657A1 (en) | Embedded biocide | |
| EP3027027B1 (en) | Biocide compositions | |
| CA2120519C (en) | Hardness suppression in urea solutions | |
| US10113101B2 (en) | Composition and method for dispersing paraffins in crude oils | |
| KR102040143B1 (en) | Method for preventing scale deposition and scale inhibitor | |
| EP3204453B1 (en) | Low molecular weight graft polymer for scale inhibitor | |
| AU2016261036B2 (en) | Composition and method for scavenging sulfides and mercaptans | |
| CN104136381B (en) | For the reduction of free oxygen and the liquid preparation of the preservation of water | |
| WO2001007682A1 (en) | Corrosion inhibition method suitable for use in potable water | |
| US7883638B2 (en) | Controlled release cooling additive compositions | |
| WO2016172502A1 (en) | Methods for inhibiting iron sulfide scale in oil wells | |
| US8828273B2 (en) | Additive formulation for industrial cooling systems | |
| US10487278B2 (en) | Alkyl diols for crude oil treatment | |
| US10214459B2 (en) | Corrosion control methods for corrosion-agressive solutions | |
| US20200032125A1 (en) | Combined uses of a phosphorous compound for iron sulphide dissolution and bacterial control | |
| JPH08283967A (en) | Production of benzotriazol based compound-containing water soluble preparation and its preparation | |
| US9750258B2 (en) | Stable composition for controlling biological growth and method for using same in oil field applications | |
| EP3711486A1 (en) | Biocidal compositions including a phosphonium quaternary cationic surfactant and methods for using same | |
| EP3691451A1 (en) | Composition and method for inhibiting microbial adhesion on surfaces | |
| WO2021247834A1 (en) | Antifouling compounds used for microbial fouling control | |
| CN115784473A (en) | Non-phosphorus scale and corrosion inhibitor with fluorescent tracing function and preparation method and application thereof | |
| JP2001252673A (en) | Method for preventing slime trouble at paper/pulp production stage water system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 2557585 Country of ref document: CA |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2005213883 Country of ref document: AU |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2005708421 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2006/009348 Country of ref document: MX |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 200580005439.2 Country of ref document: CN |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
| ENP | Entry into the national phase |
Ref document number: 2005213883 Country of ref document: AU Date of ref document: 20050221 Kind code of ref document: A |
|
| WWP | Wipo information: published in national office |
Ref document number: 2005213883 Country of ref document: AU |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2006133537 Country of ref document: RU |
|
| WWP | Wipo information: published in national office |
Ref document number: 2005708421 Country of ref document: EP |
|
| ENP | Entry into the national phase |
Ref document number: PI0506547 Country of ref document: BR |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 10589210 Country of ref document: US |
|
| WWP | Wipo information: published in national office |
Ref document number: 10589210 Country of ref document: US |
|
| WWG | Wipo information: grant in national office |
Ref document number: 2005708421 Country of ref document: EP |